Stryker Corporation announced robust first-quarter 2022 results, reporting adjusted earnings per share of $1.97, exceeding the Zacks Consensus Estimate of $1.93. Revenues reached $4.3 billion, reflecting an 8.1% year-over-year growth and outpacing revenue forecasts by 1.8%, driven by strong performances in its Trauma, Extremities, and MedSurg segments. The company is also optimistic about its full-year adjusted earnings, projecting between $9.60 and $10 per share.
“Stryker Corporation · reported · adjusted earnings · $1.97 per share”
“Stryker Corporation · expected · full-year adjusted earnings · in the range of $9.60 - $10 per share”
“Stryker Corporation · reported · first-quarter 2022 adjusted earnings per share (EPS) · $1.97”
“Stryker Corporation · beat · Zacks Consensus Estimate of EPS · $1.93”
“Stryker Corporation · reported · revenues · $4.28 billion”
“Stryker Corporation · surpassed · Zacks Consensus Estimate · 1.8%”
“Stryker Corporation · reported · revenue growth · 8.1%”
“Stryker Corporation · reported · cash and cash equivalents · $1.46 billion”
“Stryker Corporation · reported · adjusted earnings · $1.97 per share”
“Stryker Corporation · reported · revenue · $4.3 billion”
“Stryker Corporation · reported · adjusted earnings · $1.97 per share”
“Stryker Corporation · revenue for the quarter advanced · 8.1 percent year-over-year · $4.3 billion”